Patents Assigned to Dudrick Medical Research Fund I, Ltd.
  • Patent number: 5248688
    Abstract: A method and substrate composition for treating atherosclerosis are provided. The method involves parenterally administering the substrate composition as an aqueous solution to substantially lower plasma cholesterol and substantially reverse arterial plaque deposition and degenerative changes associated with atherosclerosis. The substrate compositions include mixtures of biologically active levorotatory amino acids as the antiatherosclerotic agent.
    Type: Grant
    Filed: March 4, 1991
    Date of Patent: September 28, 1993
    Assignee: Dudrick Medical Research Fund I, Ltd.
    Inventor: Stanley J. Dudrick